China Shineway Pharmaceutical Group Limited (2877.HK)

HKD 9.43

(-1.26%)

Inventory Summary of China Shineway Pharmaceutical Group Limited

China Shineway Pharmaceutical Group Limited's latest annual inventory in 2023 was 897.7 Million CNY , up 36.5% from previous year.
China Shineway Pharmaceutical Group Limited's latest quarterly inventory in 2023 FY was 897.7 Million CNY , up 36.5% from previous quarter.
China Shineway Pharmaceutical Group Limited reported annual inventory of 657.65 Million CNY in 2022, up 11.86% from previous year.
China Shineway Pharmaceutical Group Limited reported annual inventory of 587.95 Million CNY in 2021, up 32.72% from previous year.
China Shineway Pharmaceutical Group Limited reported quarterly inventory of 799.3 Million CNY for 2023 Q2, down 0.0% from previous quarter.
China Shineway Pharmaceutical Group Limited reported quarterly inventory of 897.7 Million CNY for 2023 FY, up 36.5% from previous quarter.

Annual Inventory Chart of China Shineway Pharmaceutical Group Limited (2023 - 2003)

Historical Annual Inventory of China Shineway Pharmaceutical Group Limited (2023 - 2003)

Year	Inventory	Inventory Growth
2023	897.7 Million CNY	36.5%
2022	657.65 Million CNY	11.86%
2021	587.95 Million CNY	32.72%
2020	442.99 Million CNY	2.83%
2019	430.8 Million CNY	6.24%
2018	405.49 Million CNY	44.71%
2017	280.2 Million CNY	-4.82%
2016	294.41 Million CNY	-13.63%
2015	340.85 Million CNY	19.32%
2014	285.67 Million CNY	16.85%
2013	244.48 Million CNY	19.87%
2012	203.96 Million CNY	-27.87%
2011	282.77 Million CNY	47.33%
2010	191.92 Million CNY	40.8%
2009	136.3 Million CNY	78.59%
2008	76.32 Million CNY	-2.59%
2007	78.35 Million CNY	105.13%
2006	38.19 Million CNY	7.75%
2005	35.45 Million CNY	95.16%
2004	18.16 Million CNY	-60.78%
2003	46.31 Million CNY	0.0%

Year	Inventory	Inventory Growth
2023 Q4	897.7 Million CNY	0.0%
2023 Q2	799.3 Million CNY	0.0%
2023 FY	897.7 Million CNY	36.5%
2022 FY	657.65 Million CNY	11.86%
2022 Q2	558.63 Million CNY	0.0%
2022 Q4	657.65 Million CNY	0.0%
2021 Q2	434.07 Million CNY	0.0%
2021 FY	587.95 Million CNY	32.72%
2021 Q4	587.95 Million CNY	0.0%
2020 FY	442.99 Million CNY	2.83%
2020 Q4	442.99 Million CNY	0.0%
2020 Q2	444.43 Million CNY	0.0%
2019 FY	430.8 Million CNY	6.24%
2019 Q2	354.73 Million CNY	0.0%
2019 Q4	430.8 Million CNY	0.0%
2018 Q4	405.49 Million CNY	0.0%
2018 FY	405.49 Million CNY	44.71%
2018 Q2	325.16 Million CNY	0.0%
2017 Q4	280.2 Million CNY	0.0%
2017 Q2	322.3 Million CNY	0.0%
2017 FY	280.2 Million CNY	-4.82%
2016 FY	294.41 Million CNY	-13.63%
2016 Q4	294.41 Million CNY	0.0%
2016 Q2	319.6 Million CNY	0.0%
2015 FY	340.85 Million CNY	19.32%
2015 Q4	340.85 Million CNY	0.0%
2015 Q2	312.95 Million CNY	0.0%
2014 Q4	285.67 Million CNY	0.0%
2014 FY	285.67 Million CNY	16.85%
2014 Q2	249.34 Million CNY	0.0%
2013 Q2	201.41 Million CNY	0.0%
2013 FY	244.48 Million CNY	19.87%
2013 Q4	244.48 Million CNY	0.0%
2012 Q4	203.96 Million CNY	0.0%
2012 FY	203.96 Million CNY	-27.87%
2012 Q2	224.5 Million CNY	0.0%
2011 Q2	242.94 Million CNY	0.0%
2011 Q4	282.77 Million CNY	0.0%
2011 FY	282.77 Million CNY	47.33%
2010 Q4	191.92 Million CNY	0.0%
2010 FY	191.92 Million CNY	40.8%
2010 Q2	145.5 Million CNY	0.0%
2009 FY	136.3 Million CNY	78.59%
2009 Q4	136.3 Million CNY	0.0%
2008 FY	76.32 Million CNY	-2.59%
2007 FY	78.35 Million CNY	105.13%
2006 FY	38.19 Million CNY	7.75%
2005 FY	35.45 Million CNY	95.16%
2004 FY	18.16 Million CNY	-60.78%
2003 FY	46.31 Million CNY	0.0%

Peer Inventory Comparison of China Shineway Pharmaceutical Group Limited

Name	Inventory	Inventory Difference
Pak Fah Yeow International Limited	12.19 Million HKD	-7260.081%
Grand Pharmaceutical Group Limited	1.38 Billion HKD	35.354%
Extrawell Pharmaceutical Holdings Limited	7.26 Million HKD	-12256.628%
Wai Yuen Tong Medicine Holdings Limited	308.09 Million HKD	-191.371%
Qianhai Health Holdings Limited	431.78 Million HKD	-107.906%
Lee's Pharmaceutical Holdings Limited	298.1 Million HKD	-201.138%
Essex Bio-Technology Limited	62.82 Million HKD	-1328.974%
Tongfang Kontafarma Holdings Limited	98.26 Million HKD	-813.55%
PuraPharm Corporation Limited	175.59 Million HKD	-411.233%
SSY Group Limited	1.08 Billion HKD	17.359%
JBM (Healthcare) Limited	91.58 Million HKD	-880.192%
Jacobson Pharma Corporation Limited	317.85 Million HKD	-182.425%
China Resources Pharmaceutical Group Limited	35.09 Billion HKD	97.442%